191. ウェルナー症候群
[臨床試験数:3,薬物数:4(DrugBank:3),標的遺伝子数:1,標的パスウェイ数:5]
Searched query = "Werner syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04512963 (ClinicalTrials.gov) | August 24, 2020 | 6/8/2020 | Phase I Study of Progerinin in Healthy Volunteers | A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study Including a Food Interaction Study, Followed by a Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Profile of Progerinin in Healthy Volunteers | Hutchinson-Gilford Progeria Syndrome;Werner Syndrome | Drug: Progerinin;Drug: Placebo | PRG Science & Technology Co., Ltd. | Amarex Clinical Research | Recruiting | 18 Years | 45 Years | All | 56 | Phase 1 | United States |